Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-01-10
2010-06-08
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S252140, C514S275000, C544S122000, C544S295000, C544S330000, C544S331000, C544S332000
Reexamination Certificate
active
07732444
ABSTRACT:
A heterocyclic inhibitor having the formula I, with the variables defined herein, which is useful for treating inflammatory and other physiological disorders in which PKC-theta isoform plays a role:
REFERENCES:
patent: 6335340 (2002-01-01), Gallagher et al.
patent: 6417185 (2002-07-01), Goff et al.
patent: 6492516 (2002-12-01), Liverton et al.
patent: 6541505 (2003-04-01), Dankulich et al.
patent: 6693108 (2004-02-01), Green et al.
patent: 7037918 (2006-05-01), Nuss et al.
patent: 7045519 (2006-05-01), Nuss et al.
patent: 7169798 (2007-01-01), Green et al.
patent: 2002/0156087 (2002-10-01), Nuss
patent: 2003/0109538 (2003-06-01), Carter et al.
patent: 2003/0130289 (2003-07-01), Nuss et al.
patent: 2003/0144303 (2003-07-01), Hawley et al.
patent: 2003/0149051 (2003-08-01), Green et al.
patent: 2005/0004151 (2005-01-01), Yang et al.
patent: 2005/0026967 (2005-02-01), Green et al.
patent: 2005/0256121 (2005-11-01), Jefferson et al.
patent: 2006/0009453 (2006-01-01), Geuns-Meyer et al.
patent: 2006/0089369 (2006-04-01), Nuss et al.
patent: 2006/0160817 (2006-07-01), Martinborough et al.
patent: 2006/0178388 (2006-08-01), Wrobleski et al.
patent: 2006/0293342 (2006-12-01), Chen et al.
patent: 2007/0185133 (2007-08-01), Smith et al.
patent: 2007/0225286 (2007-09-01), Ren et al.
patent: 1 816 128 (2007-08-01), None
patent: 39-5040 (1964-04-01), None
patent: WO 99/41253 (1999-08-01), None
patent: WO 01/00214 (2001-01-01), None
patent: WO 02/079197 (2002-10-01), None
patent: WO 2002/096886 (2002-12-01), None
patent: WO 03/087057 (2003-10-01), None
patent: WO 03/106451 (2003-12-01), None
patent: WO 2004/067516 (2004-08-01), None
patent: WO 2004/096797 (2004-11-01), None
Casanova et al., PubMed Abstract (Rev Neurol. 28(9):909-15) May 1999.
Hayashi et al., Protein Kinase C theta: A key player in T cell life and death, Pharmacological Research 55, pp. 537-544, 2007.
Zimmermann, Jurg, et al., “Phenylamino-pyrimidine (PAP) derivatives: a new class of potent and selective inhibitors of protein kinase C (PKC),”Arch. Pharm. Pharm. Med. Chem, vol. 329 (1996) pp. 371-376.
International Search Report issued in PCT Application No. PCT/US05/000663, which corresponds to U.S. Appl. No. 11/032,299.
“4-Pyrimidinecarboxamide, 6-(4-methoxyphenyl)-2-[(2-phenylethyl)amino]-(CA Index Name),” CAS Registry No. 552284-37-4, entered Jul. 22, 2003.
“2-Pyrimidinamine, 4-(4-methoxyphenyl)-N-[2-(2-pyridinyl)ethyl]-(CA Index Name),” CAS Registry No. 667895-75-2, entered Mar. 26, 2004.
“1H-Indole-3-ethanamine, N-[4-(4-methoxyphenyl)-2-pyrimidinyl]-(CA Index Name),” CAS Registry No. 682790-41-6, entered May 18, 2004.
“2-Pyrimidinamine, 4-(4-methoxyphenyl)-N-(2-phenylethyl)-(CA Index Name),” CAS Registry No. 682792-99-0, entered May 18, 2004.
“2-Pyrimidinamine, N-[2-(2,4-dichlorophenyl)ethyl]-4-(4-methoxyphenyl)-(CA Index Name),” CAS Registry No. 682793-00-6, entered May 18, 2004.
“2-Pyrimidinamine, N-[2-(4-fluorophenyl)ethyl]-4-(4-methoxyphenyl)-(CA Index Name),” CAS Registry No. 682793-39-1, entered May 18, 2004.
“2-Pyrimidinamine, N-[2-(3,4-dimethoxyphenyl)ethyl]-4-(4-methoxyphenyl)-(CA Index Name),” CAS Registry No. 682793-40-4, entered May 18, 2004.
“1H-Indole-3-ethanamine, N-[4-(2,4-dimethoxyphenyl)-2-pyrimidinyl]-(CA Index Name),” CAS Registry No. 682795-07-9, entered May 18, 2004.
“2-Pyrimidinamine, 4-(2,4-dimethoxyphenyl)-N-(2-phenylethyl)-(CA Index Name),” CAS Registry No. 682795-16-0, entered May 18, 2004.
“2-Pyrimidinamine, 4-(2,4-dimethoxyphenyl)-N-[2-(2-pyridinypethyl]-(CA Index Name),” CAS Registry No. 682795-19-3, entered May 18, 2004.
“2-Pyrimidinamine, 4-(2,4-dimethoxyphenyl)-N-[2-(3,4-dimethoxyphenypethyl]-(CA Index Name),” CAS Registry No. 682795-24-0, entered May 18, 2004.
“2-Pyrimidinamine, 4-(2,4-dimethoxyphenyl)-N-[2-(4-fluorophenyl)ethyl]-(CA Index Name),” CAS Registry No. 682795-85-3, entered May 18, 2004.
“2-Pyrimidinamine, N-[2-(2,4-dichlorophenyl)ethyl]-4-(2,4-dimethoxyphenyl)-(CA Index Name),” CAS Registry No. 682797-30-4, entered May 18, 2004.
“2-Pyrimidinamine, N-[2-(3,4-dimethoxyphenyl)ethyl]-4-(4-methoxyphenyl)-6-(trifluoromethyl)-(CA Index Name),” CAS Registry No. 686725-15-5, entered May 28, 2004.
“2-Pyrimidinamine, 4-(3-methoxyphenyl)-N-(2-phenylethyl)-6-(trifluoromethyl)-(CA Index Name),” CAS Registry No. 686725-36-0, entered May 28, 2004.
“2-Pyrimidinamine, N-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-methoxyphenyl)-6-(trifluoromethyl)-(CA Index Name),” CAS Registry No. 686725-37-1, entered May 28, 2004.
“2-Pyrimidinamine, 4-(3,4-dimethoxypheny1)-N-(2-phenylethyl)-6-(trifluoromethyl)-(CA Index Name),” CAS Registry No. 686725-47-3, entered May 28, 2004.
“2-Pyrimidinamine, 4-(3,4-dimethoxypheny1)-N-[2-(3,4-dimethoxyphenyl)ethyl]-6-(trifluoromethyl)-(CA Index Name),” CAS Registry No. 686725-48-4, entered May 28, 2004.
“2-Pyrimidinamine, 4-(4-methoxyphenyl)-N-(2-phenylethyl)-6-(trifluoromethyl)-(CA Index Name),” CAS Registry No. 725695-31-8, entered Aug. 12, 2004.
Chen Brendan S.
Ciavarri Jeffrey P.
Fleming Paul E.
Hone Neal D.
Reader John C.
Millennium Pharmaceuticals Inc.
Rao Deepak
LandOfFree
2-(amino-substituted)-4-aryl pyrimidines and related... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-(amino-substituted)-4-aryl pyrimidines and related..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-(amino-substituted)-4-aryl pyrimidines and related... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4171634